Related by context. All words. (Click for frequent words.) 75 metastases 74 metastatic tumors 73 renal tumors 73 renal cell carcinomas 72 GIST tumors 71 GISTs 71 lung metastases 70 seminomas 70 pulmonary metastases 70 neoplastic lesions 70 liver metastases 70 tumors 70 hyperplastic 70 neoplastic cells 70 mucinous 70 pre malignant lesions 69 lymph node metastases 69 tumoral 69 epithelial tumors 69 sarcomatoid 69 histologically 69 axillary lymph nodes 69 hamartomas 69 micrometastases 69 thrombi 69 histopathologic examination 69 nodal metastasis 69 pCR 69 osteosarcomas 69 pituitary adenomas 69 advanced adenomas 68 tumor recurrence 68 melanoma tumors 68 colorectal polyp 68 benign polyps 68 carcinoid 68 malignant lesions 68 adenocarcinomas 68 distant metastases 68 metachronous 68 calculi 68 pancreatic adenocarcinoma 68 neoplasm 68 GBM tumors 68 malignant nodules 68 lung nodules 68 breast carcinomas 68 serous ovarian cancer 68 precursor lesions 67 liver metastasis 67 colorectal carcinoma 67 HbF 67 skeletal metastases 67 lesions 67 cervical lymph nodes 67 ductal 67 cytoreductive surgery 67 breast carcinoma 67 metastatic lesion 67 neoadjuvant therapy 67 cytoreduction 67 ovarian tumors 67 lung tumors 67 neurofibromas 67 Circulating tumor cells 67 prostate carcinoma 67 metastatic lymph nodes 67 repigmentation 67 thyroid carcinoma 67 basal cell carcinomas 67 adenoma 66 schwannomas 66 gastric carcinoma 66 gastric adenocarcinoma 66 B7 H3 66 malignant growths 66 basal cell carcinoma BCC 66 echogenicity 66 carcinoids 66 paragangliomas 66 micrometastasis 66 lobular carcinoma 66 HGPIN 66 necrotic core 66 urothelial carcinoma 66 metastatic melanomas 66 lymph node metastasis 66 varices 66 neoplasms 66 peritoneal carcinomatosis 66 malignant lymphocytes 66 cell carcinomas 66 hepatocellular carcinomas 66 metastatic neuroendocrine tumors 66 tumor necrosis 66 leiomyomas 66 thyroid nodules 66 TET2 66 biochemical relapse 66 lung metastasis 66 pleomorphic 66 differentiated thyroid 66 tumor resection 66 underwent resection 66 scintigraphic 66 colorectal neoplasms 66 ovarian carcinoma 66 malignant tissue 66 R0 resection 66 sentinel nodes 66 osteoblastic 66 atherosclerotic lesions 66 preoperative chemotherapy 66 nodal metastases 66 follicular lymphomas 66 papillary 66 p# mutations 66 papillomas 66 anterior uveitis 66 chemoresistant 65 amyloid deposits 65 ADPKD 65 neoplastic 65 neovascularization 65 cellularity 65 locoregional recurrence 65 colorectal adenocarcinoma 65 anaplastic 65 polypoid 65 epithelial tissues 65 HER2 positive tumors 65 axillary nodes 65 radical nephrectomy 65 morphologic 65 malignant prostate 65 meningiomas 65 metaplasia 65 benign nodules 65 contralateral breast 65 extracranial 65 mesothelial cells 65 nonmelanoma skin cancers 65 extracapsular extension 65 histologic subtype 65 mediastinal 65 infiltrative 65 MGUS 65 colorectal tumors 65 basal cell cancers 65 resectable 65 prostate tissue 65 occult metastases 65 carcinomas 65 noncancerous cells 65 leukemic cells 65 nodular melanoma 65 precancers 65 node metastases 65 EUS FNA 65 unresectable tumors 65 adenomatous polyps 65 invasive ductal 65 percutaneous biopsy 65 BCR ABL mutations 65 neoplasia 65 malignant neoplasm 65 leiomyoma 65 invasive carcinoma 65 metastatic cancers 65 neovascular 65 colorectal liver metastases 65 fibrin deposition 65 oncologic outcomes 65 K ras mutations 65 Gleevec resistant 65 histologically proven 65 lymphovascular invasion 65 urothelial cancer 65 hypoperfusion 65 proteoglycan 65 neuroblastoma tumors 65 breast lesions 65 infarcts 65 supratentorial 65 prostate cancer CaP 65 FDG uptake 65 tumor 65 amyloid deposition 64 lymph node involvement 64 rebleeding 64 intestinal metaplasia 64 completely resected 64 lipomas 64 endometrial carcinoma 64 lesional 64 neuroendocrine tumors 64 HER2 amplification 64 mitomycin C 64 atypical hyperplasia 64 radiochemotherapy 64 postoperative chemotherapy 64 CIN2 + 64 adenomatous 64 lymphatic tissue 64 choroidal 64 kidney cysts 64 axillary node 64 bladder tumors 64 myofibroblasts 64 pre cancerous polyps 64 parenchymal 64 NMIBC 64 Histologically 64 locoregional disease 64 inflammatory lesions 64 CIN3 64 axillary dissection 64 mTOR inhibitors 64 parenchyma 64 adenomatous polyp 64 mesotheliomas 64 SLNB 64 debulking surgery 64 premalignant 64 microglial activation 64 HER2 positive cancers 64 distant metastasis 64 squamous 64 cisplatin resistant 64 PCa 64 remyelination 64 carcinoid tumors 64 brain parenchyma 64 HER2 expression 64 Immunohistochemical analysis 64 metastatic tumor 64 prostate adenocarcinoma 64 CLL cells 64 squamous cell cancers 64 cytogenetic responses 64 axillary node dissection 64 papillary renal cell carcinoma 64 ALK mutations 64 hyperplastic polyps 64 hyperoxaluria 64 brain lesions 64 metastatic disease 64 lung adenocarcinomas 64 EGFr 64 CMV infection 64 intestinal polyps 64 pelvic lymphadenectomy 64 hypertrophic scars 64 cytokeratin 64 prostatic tissue 64 BRAF mutation 64 melanocytic nevi 64 breast cancer subtypes 64 enucleation 64 pathologic examination 64 T2 lesions 64 cystic lesions 64 uveal melanoma 64 sentinel node 64 thyroglobulin 64 intraoperative complications 64 malignant transformation 64 glioblastoma tumors 64 invasive carcinomas 64 E cadherin expression 64 malignant tumors 64 pancreatic carcinoma 64 premalignant lesions 64 SUVmax 64 trophoblast cells 64 vestibular schwannomas 64 hepatocellular carcinoma 64 EGF receptors 63 gastrointestinal stromal tumors GIST 63 osteoid 63 pleural fluid 63 radioiodine therapy 63 nutlin 3a 63 complete cytogenetic response 63 Polyps 63 chromosomal rearrangement 63 retroperitoneal 63 tumor regressions 63 Mitomycin C 63 colorectal tumor 63 hematologic toxicity 63 endostatin 63 lymphadenectomy 63 prostate carcinomas 63 colorectal carcinomas 63 neoadjuvant chemotherapy 63 splenic 63 tumor shrinkage 63 microsatellite instability 63 sentinel lymph node biopsy 63 nephrectomy 63 pT3 63 hypervascular 63 tumor biopsies 63 tunica vaginalis 63 mesenteric 63 Tumor shrinkage 63 metastasis 63 locoregional 63 esophageal tumors 63 choroidal neovascularization 63 HSCT 63 HNSCC 63 mediastinal lymph nodes 63 Malignant tumors 63 pancreatectomy 63 EGFR mutations 63 CIN3 + 63 basal cell nevus syndrome 63 Papillary 63 metastatic bladder 63 neuroblastomas 63 Hurthle cell 63 chemo resistant 63 immunocompetent 63 biochemical recurrence 63 haematopoietic 63 benign neoplasms 63 telomerase inhibition 63 malignant pleural mesothelioma 63 cystectomy 63 OGG1 63 molecular abnormalities 63 squamous cell carcinoma SCC 63 graft dysfunction 63 KRAS mutation 63 uPA 63 granzyme B 63 malignant pancreatic 63 p# mutation 63 pre cancerous growths 63 metastatic RCC 63 KRAS mutations occur 63 lymphadenopathy 63 polypoid lesions 63 cutaneous lesions 63 endoleaks 63 recanalization 63 MALT lymphoma 63 neointimal 63 pathologic diagnosis 63 biopsy specimen 63 EGFR receptor 63 echogenic 63 nonsmall cell lung cancer 63 ALND 63 TRAIL R1 63 osteochondromas 63 carcinoid tumor 63 neuroendocrine cancers 63 gadolinium enhanced 63 orthotopic 63 PARP inhibition 63 hematopoietic cells 63 intraductal 63 endometrial cancers 63 INCB# [003] 63 eosinophil count 63 ADAMTS# 63 KIT mutations 63 Candida infection 63 radiographic findings 63 cervical lesions 63 intracranial hemorrhage ICH 63 prostatic 63 cytotoxic therapies 63 astrocytomas 63 androgen deprivation 63 liver resection 63 pT2 63 renal carcinoma 63 ductal breast cancer 63 luminal 63 ascites 63 lymph node dissection 63 squamous cell lung cancer 63 neovascularisation 63 carcinoma 63 histologic 63 renal pelvis 63 benign lesions 63 bone metastasis 63 trabecular bone 63 grade cervical intraepithelial 63 basal cell skin 63 thyroid nodule 63 histopathologic findings 63 acinar 63 imatinib therapy 63 precancerous lesion 63 gastrointestinal stromal tumors 63 allogeneic HSCT 63 mammographically 63 pseudoaneurysm 63 tau aggregates 63 lobular 63 PrPSc 63 histological subtype 63 MYCN amplification 62 bladder carcinoma 62 gastric cancers 62 IL 1ß 62 polyps growths 62 xenograft tumors 62 breast tumors 62 PSADT 62 cell carcinoma 62 Lymph nodes 62 noncalcified 62 NP CRNs 62 advanced adenoma 62 antiangiogenic therapy 62 lung carcinomas 62 urothelium 62 brain metastases 62 adjuvant radiotherapy 62 proximal colon 62 ductal cancer 62 Benign tumors 62 HER2 overexpression 62 transgene expression 62 WT1 62 biliary tract cancer 62 pre cancerous lesions 62 histologies 62 microvessel density 62 keloid 62 nephrotoxicity 62 metastatic malignant melanoma 62 resected 62 leiomyosarcoma 62 KRAS mutations 62 immunoreactivity 62 grade gliomas 62 perfusion abnormalities 62 prognostic indicator 62 hypervascular tumors 62 Basal cell 62 adenomas 62 Gliomas 62 transmural 62 axillary lymph node 62 Radical prostatectomy 62 tumor metastases 62 trabeculectomy 62 anti angiogenic therapies 62 CMV disease 62 antitumor effect 62 peritumoral 62 BRAF mutations 62 hepatocellular cancer 62 glioblastomas 62 normal karyotype 62 concurrent chemoradiation 62 prostate epithelial cells 62 vessel occlusion 62 cytostatic 62 nodular 62 micronuclei 62 lesion 62 biodistribution 62 choroid 62 cerebrospinal fluid CSF 62 PCNSL 62 renal cysts 62 squamous carcinoma 62 adrenalectomy 62 effector functions 62 myeloproliferative diseases 62 NNRTI resistance 62 esophagogastric junction 62 cancerous polyps 62 pancreatic cancers 62 lobular carcinomas 62 endometrial cells 62 EGFR inhibitors 62 sentinel lymph nodes 62 Tumours 62 Immunohistochemical staining 62 penetrating keratoplasty 62 epithelial cell 62 TGF ß1 62 calcified plaques 62 PAOD 62 ischemic lesions 62 mesangial 62 fibroma 62 lymphoid cells 62 p# biomarker 62 fibrotic disease 62 core needle biopsy 62 explants 62 mediastinum 62 mRNA expression 62 vascularization 62 cisplatin chemotherapy 62 chromosomal aberrations 62 TIMP 62 EBRT 62 endobronchial 62 eccrine 62 histologic subtypes 62 operable breast cancer 62 chemoembolization 62 cranial irradiation 62 lymphoid tissues 62 geographic atrophy 62 H. pylori eradication 62 intravesical therapy 62 bladder cancers 62 hemorrhagic complications 62 posterior fossa 62 lacrimal gland 62 intrahepatic 62 thoracoscopic lobectomy 62 HCV replication 62 Adenomas 62 germline mutations 62 surgical excision 62 taxane therapy 62 Squamous cell carcinomas 62 CD# + [001] 62 reimplantation 62 ependymomas 62 hyaline cartilage 62 acute GvHD 62 bronchogenic carcinoma 62 somatic mutations 62 hepatic metastasis 62 complete remissions 62 malignancy 62 malignancies 62 epithelia 62 colonic mucosa 62 RKIP 62 Histological examination 62 hepatoma 62 lymphoid 62 Aortic valve 62 malignant lymphomas 62 malignant lymphoma 62 radical prostatectomy RP 62 metastatic 62 PDGFR 62 biochemical marker 62 sonographically 62 IgG4 62 pancreatic tumor 62 underarm lymph nodes 62 hepatectomy 62 genital tract infections 62 keloid scars 62 intravenous bisphosphonates 62 precancerous cervical 62 EGFRIs 62 HER2 receptor 62 Cholangiocarcinoma 62 lymphoid organs 62 submucosa 62 papillary carcinoma 62 epithelial ovarian 62 p# activation 62 urothelial 62 tumor regression 62 focally 62 superficial bladder cancer 62 myelomas 62 seminal vesicle invasion 61 granulomas 61 osteolytic 61 gastroesophageal junction 61 myocytes 61 allogeneic bone marrow 61 macrophage infiltration 61 ximelagatran 61 transurethral resection 61 fibrillin 61 Leydig cell 61 dysplastic lesions 61 spinal metastases 61 Barrett esophagus BE 61 contractile muscle 61 myoma 61 colorectal adenoma 61 infective endocarditis 61 hepatocellular carcinoma HCC 61 wedge resection 61 recurrent glioblastoma multiforme 61 aneurysm sac 61 myxoid 61 cervical intraepithelial neoplasia 61 Lymph node 61 synovial 61 adjuvant therapies 61 pheochromocytoma 61 synovial tissue 61 lymph node removal 61 PSA nadir 61 aplasia 61 cartilage lesions 61 transfusion syndrome 61 proliferative diabetic retinopathy 61 colon tumors 61 choroidal neovascularization CNV 61 mucosal tissue 61 hA# 61 serum PTH 61 chronic periodontitis 61 cancerous lesions 61 pleural mesothelioma 61 immunostaining 61 precancerous condition 61 TTR gene 61 medically inoperable 61 proton MR spectroscopy 61 Doxil ® 61 conventional angiography 61 submucosal 61 needle aspiration 61 P. acnes 61 lactate dehydrogenase LDH 61 DCIS lesions 61 CR nPR 61 cardiac dysfunction 61 serum calcium levels 61 antiangiogenic agents 61 ALT flares 61 atheroma volume 61 TGF β 61 VEGF receptor 61 Squamous 61 atherosclerotic lesion 61 lactate dehydrogenase 61 metastatic prostate 61 chronic GVHD 61 DSAEK 61 extrahepatic 61 corneal graft 61 hematopoietic cancers 61 hamartoma 61 tumor xenograft models 61 partial remissions 61 postoperative morbidity 61 thymic carcinoma 61 receptor tyrosine kinase inhibitor 61 hydronephrosis 61 precancerous tissues 61 cyclin E 61 pancreatic tumors 61 allogeneic transplant 61 beta catenin protein 61 hyperplasia 61 metastatic cancer 61 pulmonary metastasis 61 thymoma 61 histopathological 61 stromal 61 Metastatic 61 dysplastic 61 azacytidine 61 ductal carcinomas 61 Surgical excision 61 neointimal hyperplasia 61 precancer 61 precancerous polyp 61 lymph nodes 61 curative resection 61 heterotopic ossification 61 NSCLC tumors 61 lung nodule 61 GBMs 61 heavily pretreated patients 61 germline mutation 61 anti angiogenic agents 61 opacification 61 radiotherapy RT 61 VEGF expression 61 perfusion defects 61 isotypes 61 hepatic metastases 61 intra ocular pressure 61 epididymal 61 atherosclerotic plaques 61 colorectal polyps 61 senescent cells 61 mesothelin 61 prognostic variables 61 macroalbuminuria 61 paraprotein 61 carotid plaque 61 activated microglia 61 p#HER# 61 xenograft models 61 lymphocytic 61 tumor subtypes 61 specific antigen PSA 61 Surgical resection 61 polyposis 61 paroxysmal AF 61 CYT# potent vascular disrupting 61 F FDG uptake 61 medullary thyroid cancer 61 gene amplification 61 ocular melanoma 61 biliary tree 61 pre cancerous lesion 61 MAPK pathway 61 immunohistochemical analysis 61 axilla 61 mesenchymal cells 61 oblimersen 61 microcalcifications 61 VEGF inhibition 61 N. gonorrhoeae 61 epidermal cells 61 ependymoma 61 somatostatin receptors 61 trans retinoic acid 61 Adjuvant chemotherapy 61 chemoradiotherapy 61 hormone receptor negative 61 underwent surgical resection 61 T2 weighted images 61 nephron sparing surgery 61 HRCT 61 aminotransferases 61 neoadjuvant 61 factor PlGF 61 pancreatic lung 61 neuropilin 61 TGF ß 61 motoneurons 61 urine cytology 61 glomerular 61 sclerosing 61 baseline LDH 61 castrate resistant 61 immunohistochemical staining 61 AV fistulas 61 adjuvant radiation 61 lymphoid tissue 61 lymphoid tumors 61 PKCi 61 pancreatic prostate 61 myelofibrosis polycythemia vera 61 mononuclear cells 61 LRAT 61 malignant cells 61 carcinoembryonic antigen 61 nonischemic 61 EphA2 61 ENMD # 61 malignant polyps 61 surgical debulking 61 plexiform neurofibromas 61 FDG PET 61 Mesenchymal 61 fluoroquinolone resistance 61 radiologically 61 aneurysm rupture 61 leukaemias 61 histologic findings 61 poorer prognosis 61 cystic lesion 61 TGF alpha 61 F FDG PET 61 benign moles 61 oropharyngeal 61 TNFa 61 microtubule targeting 61 JMML 61 Recurrences 61 complete cytogenetic 61 cutaneous melanoma 61 AK lesions 61 comedones 61 mutated KRAS 61 rhIL 7 61 TOP2A 61 myeloproliferative disorder 61 ß amyloid 61 microbleeds 61 TACE 61 clinically localized prostate 61 neuroblastoma cells 61 Bezielle 61 daunorubicin 61 gastric mucosa 61 incisional 61 tissue biopsies 61 melanoma lesions 61 precancerous cervical lesions 61 infantile hemangiomas 61 CD# expression [001] 60 nodal dissection 60 leukemic cell 60 angiosarcoma 60 prognostic markers 60 fibroadenomas 60 BRAF V#E mutation 60 5FU 60 Doppler sonography 60 Brain metastases 60 histological subtypes 60 pneumonectomy 60 pleurodesis 60 mutant p# 60 Cancerous cells 60 osteoid osteoma 60 ADPKD patients 60 intratumoral 60 clinicopathologic 60 tumor excision 60 TNF blocker therapy 60 histological examination 60 cervical carcinoma 60 alveolar epithelial cells 60 effector function 60 TP# mutations 60 leukemia AML 60 sonographic findings 60 ultrasonographic 60 IGFBP 3 60 Sjögren syndrome 60 cranial radiation 60 collagen degradation 60 N Myc 60 tracer uptake 60 para aortic 60 EGFR mutation 60 tumor perfusion 60 intact parathyroid hormone 60 sleeve lobectomy 60 systemic toxicity 60 BMPR2 60 alkaline phosphatase ALP 60 cervical lymph node 60 activating mutations 60 pancreatic endocrine 60 protein albumin 60 CCL# 60 aneurysmal 60 cholangiocarcinoma 60 extramedullary 60 vitamin D analogs 60 thrombotic complications 60 basal cell 60 haematological 60 stented vessel 60 EGFR protein 60 NF kB pathway 60 thymectomy 60 stem progenitor cells 60 molecular subtypes 60 SSc 60 gene rearrangements 60 cardiac allograft vasculopathy 60 varicoceles 60 Fas ligand 60 T2 weighted MRI 60 renal cortical 60 hepatic fibrosis 60 parathyroidectomy 60 chemotherapeutic regimens 60 inducible nitric oxide synthase 60 endoscopic resection 60 TGF beta signaling 60 Cysts 60 cytoprotective 60 hypermethylation 60 teratoma 60 telangiectasia 60 corneal neovascularization 60 inhibitory effects 60 heavily pretreated 60 vascular lesion 60 #F FDG PET 60 leukemic stem cells 60 response pCR 60 interferon beta therapy 60 axonal regeneration 60 Capsule endoscopy 60 adrenocortical cancer 60 carcinomatosis 60 interstitium 60 Symadex 60 EGFRvIII 60 Endometrial 60 imatinib Gleevec 60 myometrium 60 ductal adenocarcinoma 60 neoplasias 60 pro angiogenic 60 trophoblasts 60 antiangiogenic 60 EGF receptor 60 prostate tumor 60 bleomycin 60 photocoagulation 60 resections 60 neuroendocrine carcinoma 60 primary cilia 60 allograft rejection 60 PASI scores 60 colorectal metastases 60 lymphocytosis 60 atypical ductal hyperplasia 60 hepatic arterial 60 corneal ectasia 60 endometrial hyperplasia 60 Metastases 60 Aβ 60 malignant cancerous 60 transfected cells 60 axillary 60 perfusion defect 60 LVNC 60 E. faecalis 60 cerebral vasospasm 60 medulloblastomas 60 nonmetastatic 60 anti angiogenic drugs 60 antiproliferative effects 60 tumor cells 60 malignant pheochromocytoma 60 vascularity 60 lymphangiogenesis 60 highly vascularized 60 systolic dysfunction 60 lytic 60 hypoechoic 60 endometrial 60 troponin T 60 thioredoxin 60 troponins 60 PTPN# 60 relapsed MM 60 pretransplant 60 anti angiogenic therapy 60 FGFR2 60 colonic polyps 60 chromosomal mutations 60 Aurora kinase 60 chemoradiation therapy 60 FDG-PET/CT 60 squamous cells 60 histological diagnosis 60 ccRCC 60 natriuretic peptides 60 Glioma 60 cytological 60 P selectin 60 flavopiridol 60 symptomatic paroxysmal AF 60 immunomodulation 60 androgen suppression therapy 60 curability 60 cytologically confirmed 60 endothelial activation 60 CCyR 60 thrombocytopenic patients 60 Plain radiographs 60 cortical bone 60 resected tumors 60 lumbar disc herniation 60 bacterial colonization 60 carotid stenosis 60 BCCs 60 rectal cancers 60 IGFBP 60 papillary RCC 60 paclitaxel eluting stents 60 tissue fibrosis 60 EGFR pathway 60 vWF 60 colonoscopic 60 recurrent NSCLC 60 Colon polyps 60 nonproliferative 60 melanomas 60 ventricular myocardium 60 transarterial 60 leukemic blasts 60 β amyloid 60 EpCAM 60 chemosensitivity 60 hippocampal neurons 60 glioblastoma tumor 60 infarcted myocardium